SUN PHARMA ADVANCED RESEARCH C financial statements, including revenue, expenses, and profit
The total revenue of SPARC for the last quarter is 149.10 M INR, and it's 15.94% higher compared to the previous quarter. The net income of Q3 24 is -795.10 M INR.